Skin-cap

Quick links to important sections

Skin-cap

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Skin-cap

Quick Facts

Property Description
Active ingredient Pyrithione Zinc (Zinc Pyrithione)
Form Cream, Aerosol Spray, Shampoo, Body Wash
Pharmacological class Topical Antifungal, Antibacterial, and Cytostatic Agent
Route Topical (External)
Origin Synthetic Coordination Complex

What Type of Dermatological Preparation is Skin-cap?

Skin-cap is a dermatological preparation defined as a non-steroidal Topical Antifungal, Antibacterial, and Cytostatic Agent, utilized for application directly onto the skin surface. This medicinal entity's classification emphasizes its multi-functional role in managing skin surface dysregulation, notably differing from preparations like topical corticosteroids. The active substance's high-level classification includes Antifungal Agents and Organometallic Compounds. Its non-steroidal identity provides a relevant therapeutic alternative focused on localized microbial control and cell proliferation management.


Composition and Available Forms of Skin-cap

The preparation's activity is driven by the single active ingredient Pyrithione Zinc, a synthetic coordination complex of zinc and pyrithione. Pyrithione Zinc functions as the medicinal core, giving the product its topical efficacy. Skin-cap is specifically known for offering a complete system of Over-The-Counter (OTC) dosage forms for both skin and scalp application, which typically include an emulsified cream, an aerosol spray, a shampoo, and a body wash. The preparation's low solubility ensures that the Pyrithione Zinc particles are deposited and retained on the skin surface for sustained activity. The compound is used as an antifungal and antiseborrheic agent.


General Purpose of Pyrithione Zinc in Skin Management

The overarching purpose of the active ingredient is to restore the stability of the skin environment by regulating epidermal cell proliferation and controlling microbial growth. This mechanism relies on exerting a cytostatic effect to help normalize the accelerated turnover of skin cells, while simultaneously providing a broad antimicrobial spectrum. For individuals dealing with persistent flaking and surface irritation, the product's general therapeutic benefit is the mitigation of visible surface dysregulation, such as scaling and flaking. The approach focuses on providing symptomatic relief from the manifestations of skin surface dysregulation, addressing the underlying cellular and microbial factors.

What side effects are possible with Skin-cap?

Possible Side Effects and Safety Information

The safety profile for topical Pyrithione Zinc, the active ingredient in Skin-cap, is structured by government regulatory documents based on documented adverse reactions and use constraints. The adverse event profile is primarily localized to the application area, reflecting the drug’s topical application.


Documented Adverse Reactions

The most frequently documented adverse reactions, generally classified as less common or rare in regulatory sources, involve the skin and subcutaneous tissue. These reactions are typically localized to the site of application and include:

  • Skin irritation
  • Stinging or burning of the scalp
  • Skin peeling (Desquamation)

Serious Reactions and Safety Constraints

A severe allergic reaction (Hypersensitivity) is listed in official labeling as a serious adverse reaction, though it is rare. Signs of this reaction, as formally documented, can include rash, hives, swelling of the face or throat, wheezing, or difficulty breathing.

Constraint Type Regulatory Status/Requirement
Route Restriction Strictly for external use only.
Local Hazard Mandatory warning to avoid contact with the eyes.
Contraindication Not for use in individuals with known hypersensitivity to the ingredients.

Population-Specific Safety Notes

Official prescribing information addresses use in specific populations:

  • Pediatric and Geriatric Use: Adverse effects are not expected to differ significantly in these age groups compared to younger adults.
  • Pregnancy and Lactation: Regulatory documents note the lack of adequate and well-controlled studies in pregnant women and the absence of data regarding excretion into human milk. Use during these periods must be assessed by weighing the potential benefits against the potential risks according to established regulatory guidance.

Overdose and Emergency Response

Overdose of topical preparations containing pyrithione zinc, such as Skin-cap, is primarily addressed by regulatory authorities in the context of accidental ingestion, rather than issues arising from excessive topical use. Official documentation states that the development of specific systemic overdose symptoms from external application is considered unlikely, reflecting the product's design for minimal cutaneous absorption.

The most critical regulatory action is the mandate to seek immediate medical attention and contact a Poison Control Center right away if the preparation is swallowed. This requirement is universal, but regulatory warnings highlight the specific risk of accidental ingestion in the pediatric population, emphasizing the need for prompt response.

In the event of confirmed accidental ingestion, the official management strategy relies solely on supportive and symptomatic measures. Regulatory documentation outlines specific procedural guidance for healthcare professionals, which includes the instruction to not induce vomiting and to not perform gastric lavage. This is crucial to prevent aspiration, aligning the entire overdose profile with the need for urgent help-seeking and standardized supportive clinical care rather than listing detailed symptomology.

Therapeutic Uses of Skin-cap

What Skin-cap Treats: Main Uses and Benefits

This preparation is commonly used for managing chronic scalp and skin disorders, including Seborrheic Dermatitis and recurrent dandruff. It is relevant for situations involving excessive scaling, flaking, and pruritus (itching), which are the hallmark symptoms of these conditions. This application focuses on managing these specific symptomatic patterns.

The preparation supports symptomatic relief for the associated discomforts that often accompany chronic skin surface dysregulation. It is applied across domains where patients experience pruritus (itching) and localized redness, assisting with easing these challenging manifestations and supports patients during episodes of heightened discomfort. For individuals managing chronic conditions like localized Psoriasis, particularly when symptoms involve the scalp, it provides supportive relief. This supports general well-being during symptomatic phases, assisting with general patient comfort.

“The preparation is commonly used for managing the visible symptoms of chronic scaling and associated skin irritation.”


Quick Fact: Relief for Flaking
Main Use Is used for managing chronic flaking and scaling (dander).
Symptom Eased Pruritus (itching) and irritation of the skin/scalp.
Context Applied during periods of recurrent/episodic manifestations of seborrhea.
Patient Benefit Contributes to improved day-to-day comfort during symptomatic periods.

Regulatory References

  1. U.S. National Library of Medicine's DailyMed overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Skin-cap — Official Regulatory Information

The eligibility profile for Skin-cap (Pyrithione Zinc) is strictly defined by regulatory documents, establishing who is permitted to use the topical preparation.


Eligibility Scope

Classification Population Status Restriction Detail
Contraindicated Individuals with Hypersensitivity Prohibited for those with a known allergy to Pyrithione Zinc or any excipient.
Contraindicated Children Under 2 Years of Age Use is not recommended and is prohibited for unsupervised OTC application.
Restricted Use Pregnant Women Use is conditional; requires physician consultation to ensure maternal benefit outweighs potential fetal risk.
Restricted Use Breastfeeding Women Safety is unknown; use is conditional and requires physician consultation due to a lack of data on excretion into human milk.
Permitted Adults and Older Children Allowed for individuals aged two years and older who have no known contraindications.

Eligibility-Related Restrictions

Use is strictly for external, topical application only; the preparation must not be ingested, nor used in the eyes. Individuals requiring application over a large area of the body should first consult a healthcare professional. Official regulatory documents define these eligibility constraints by focusing on ingredient safety, age, and reproductive status, without discussing therapeutic efficacy or symptom relief.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Restrictions and Risks

The interaction profile for this preparation is primarily structured by a mandatory restriction on use documented by regulatory authorities. The U.S. Food and Drug Administration (FDA) has issued an official alert advising against the use of the Skin-cap Aerosol Spray product. This restriction stems from the confirmed presence of an undisclosed high-potency glucocorticosteroid within the formulation, which introduces systemic interaction risks not associated with the labeled active component.

Pharmacodynamic and Exposure Risks

The presence of the undisclosed steroid establishes the core interaction risk as a pharmacodynamic reinforcement with other corticosteroids. Co-administration with other systemic or topical steroids can lead to cumulative exposure, increasing the potential for serious systemic effects, such as reversible hypothalamic-pituitary-adrenal (HPA) axis suppression. This unintended exposure represents a documented exposure-modifying interaction associated with the product name.

Labeled Active Ingredient Profile

Regulatory monographs for the labeled active ingredient, Pyrithione Zinc, document a negligible risk of classical systemic drug-drug interactions due to its topical route and minimal absorption. No specific timing-based interaction rules or interactions with food, alcohol, or herbal products are documented in official labeling.

Population-Specific Cautions

Interaction severity is formally heightened in sensitive groups, serving as a population-specific interaction note. This heightened systemic risk is a caution particularly relevant for pediatric patients and individuals with compromised skin barriers.

Mechanism of Action

The pharmacological effects of Pyrithione Zinc are governed by a dual-action mechanism encompassing microbial inhibition and epidermal cell proliferation control, sustained by the compound's localized surface deposition.

Targeting Microbial Energy Metabolism

The drug acts as an ionophore, facilitating the transport of copper ions into the fungal cell, which causes mismetallation and inactivation of essential Iron-Sulfur Cluster Proteins ( Fe-S) in the mitochondria. This action halts the microbe's Electron Transport Chain, creating a critical ATP shortage and results in the inhibition of microbial growth (e.g., Malassezia yeast) on the skin surface.

Modulating Epidermal Cell Proliferation

Pyrithione Zinc exerts a cytostatic effect by inducing cellular stress signals in rapidly dividing skin cells (keratinocytes). This involves activating the Volume-Regulated Anion Channels ( VRAC) and triggering DNA damage signals that activate the PARP enzyme. These cascades restrict the accelerated rate of cell division, resulting in a regulated decrease in epidermal cell turnover.

Mechanism Persistence via Surface Deposition

The mechanism is sustained by the drug's low aqueous solubility, which facilitates the retention and deposition of the particulate compound on the skin surface following application. This establishes a slow-release reservoir for the compound, extending the duration of the antimicrobial and cytostatic physiological modulations.

Dosage and Administration Information

How to Use Skin-cap

The use of this preparation is confined to external, non-systemic application of its active ingredient, Pyrithione Zinc. Administration principles define the route, frequency, and population-specific rules across the available dosage forms, such as cream, spray, and shampoo.


Administration Scope

Feature Standard Parameters
Route of administration Topical (External use only).
Dosing schedule (General) Apply a thin layer (cream/spray) or a liberal amount (shampoo) to the affected skin areas. Concentrations typically range from 0.125% to 2%.
Frequency schedule Wash-off forms: Used at least twice a week for maintenance. Leave-on forms: Applied up to four times daily to the affected site.
Preparation requirements Requires applying to wet skin/hair for wash-off products; some liquid forms must be shaken well prior to use.
Age-group administration rules Use is not authorized for children under 2 years of age, except when specifically directed by a licensed physician.

Procedural Structure

The overarching use protocol dictates distinct procedural requirements based on the formulation type. Wash-off products, such as the shampoo, require massaging to lather, thorough rinsing, and an optional repeat of the application. Conversely, leave-on products like the cream or spray are applied directly and are not to be rinsed off.

The use protocol also includes a mandatory procedural constraint to avoid contact with the eyes during application; eyes must be rinsed thoroughly with water if accidental contact occurs. This framework standardizes the appropriate way to administer the medicine across its different forms.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Skin-cap

Evidence for Use in Seborrheic Dermatitis and Dandruff

Clinical research exploring Pyrithione Zinc, the active component in Skin-cap, was studied for conditions characterized by scaling, redness, and itching associated with these conditions. The evidence base, as reported in scientific literature, is primarily derived from short-term, randomized controlled trials (RCTs). These studies included vehicle-controlled studies and trials where the active ingredient (usually in a shampoo formulation) was evaluated alongside an existing therapy. Researchers monitored outcomes related to physical discomfort, including measuring changes in scaling (flaking) and erythema (redness), as well as patient-reported outcomes describing perceived discomfort, such as pruritus (itching).

Findings from numerous trials reported changes measured in clinical scores over the short-term study period (2 to 6 weeks). Studies also monitored laboratory outcomes, reporting patterns related to measurements of the skin surface's fungal burden, specifically the count of Malassezia yeast.

Key Evidence Gaps and Areas for Further Research

While many studies contribute to the broader evidence landscape for the active ingredient, certainty remains low regarding the outcomes of non-shampoo forms due to historical factors. Earlier, proprietary product formulations were associated with the presence of undisclosed potent corticosteroids, which complicated the interpretation of initial findings for the zinc pyrithione component alone.

The evidence base for Localized Psoriasis is based on a smaller number of studies compared to the research for dandruff. Research was studied for patients with conditions involving times when symptoms become more noticeable. The results apply only to the populations studied, and long-term effects for specific application forms are not fully established.

Key Studies & References

  1. Antidandruff Shampoo (Pyrithione Zinc) - U.S. National Library of Medicine DailyMed Overview
  2. Pyrithione Zinc (D01AE17) - World Health Organization (WHO) ATC/DDD Index

Frequently Asked Questions (FAQ)

Common questions about Skin-cap (FAQ)


Q: Is Skin-cap available to buy over the counter?

A: The active component in this product, Pyrithione Zinc, is authorized by regulatory bodies for use in over-the-counter (OTC) products. This classification is typically for products treating conditions like dandruff and seborrheic dermatitis. This means the product can generally be purchased without a prescription where this classification applies.


Q: How quickly can I expect Skin-cap to start working?

A: Official administration instructions advise users to apply the product regularly, such as at least twice a week, to achieve and maintain control over symptoms. Regulatory documents do not provide a specific timeline, such as a set number of days, for when a person should expect to notice initial effects. Continued use as directed is generally necessary for the full benefit.


Q: What happens if I forget to use Skin-cap for a day?

A: If an application is missed, official patient information suggests applying it as soon as you remember. If the time is near for the next scheduled application, it is recommended that the missed one be skipped entirely, and the regular schedule be resumed. It is specified that extra amounts are typically not recommended to make up for a forgotten application.


Q: Is Skin-cap meant for long-term skin maintenance?

A: The product is indicated to help control the symptoms of seborrheic dermatitis and dandruff, often involving application advice for ongoing use, such as twice a week for maintenance. However, official warnings describe discontinuing use if the condition worsens or if there is no improvement after regular use. The established long-term effects for specific application forms are not fully conclusive in all regulatory research summaries.


Q: What should I do if my skin reacts badly to Skin-cap?

A: Regulatory labels advise stopping the use of the product immediately if signs of irritation, rash, or worsening of the skin condition occur. These labels also specify seeking medical advice if these adverse effects persist or if the condition does not improve after following the regular directions.


Q: Does Skin-cap interact with any common vitamins or supplements?

A: Due to the product’s topical application and minimal absorption into the bloodstream, the labeled active ingredient has a negligible risk of classical systemic interactions. Official regulatory information, however, generally advises users to inform their doctor about all prescription or nonprescription medicines, vitamins, or supplements being taken when starting any new product.


Q: What is the difference between the Skin-cap cream and the spray?

A: Regulatory guidelines confirm that different dosage forms, such as creams and sprays, have distinct administration protocols. For example, some forms are intended as 'leave-on' products, while others may be 'wash-off' products, each with a specific required application frequency. The non-active ingredients providing the texture and consistency will also vary between formulations.


Q: Is the zinc pyrithione in Skin-cap different from other products?

A: The labeled active component, Pyrithione Zinc, is a chemically standardized substance. The concentrations used in over-the-counter anti-dandruff and seborrheic dermatitis products are typically within a specific range established in regulatory monographs.


Q: Can sun exposure affect how Skin-cap works?

A: Scientific studies on the active ingredient indicate that it can be rapidly transformed when exposed to ultraviolet light, a process known as photolysis. While this is not an official user warning, this suggests that high or prolonged sun exposure could potentially reduce the effectiveness of the product on the skin surface.


Q: Is Skin-cap effective for fungal skin issues?

A: Official information describes the action of the active ingredient as fungistatic, meaning its mechanism is described as inhibiting the growth and cell division of fungi. This mechanism specifically targets Malassezia yeast, which is understood to be the primary factor in conditions like dandruff and seborrheic dermatitis.


Q: Can Skin-cap be used on broken or infected skin?

A: Regulatory labels advise users to consult with a doctor before using the product if they have a condition that covers a large area of the body. Furthermore, some official product labels describe limitations on application to broken skin, open wounds, or existing infections.


Q: What is the ingredient that provides the moisturizing effect?

A: The specific moisturizing effect is provided by various inactive ingredients present in the formulation, which are compounds added for texture and conditioning rather than therapeutic action. Regulatory documents require all these inactive ingredients, which may include conditioners like Glycol Stearate, to be fully listed on the product label.


Q: Is Skin-cap safe to use if I have other medical conditions?

A: The regulatory label requires users to seek advice from a doctor before using the product if they have a condition covering a large area of the body. This is a general caution related to any underlying health issues that could potentially be affected by topical application.


Q: How should I store Skin-cap products?

A: Regulatory guidelines describe products as typically being stored locked and out of the reach of children. The containers are required to be kept tightly closed and protected from extreme temperatures, such as excessive heat, freezing, or direct sunlight, to maintain stability.


Q: Is Skin-cap gluten-free or suitable for people with allergies?

A: Regulatory warnings describe the product as contraindicated for use by individuals with a known hypersensitivity to any of the ingredients. Regarding allergies to components like gluten, this status is not consistently mandated by regulatory bodies and this status requires confirmation against the product’s specific inactive ingredient list.


Q: Why is Skin-cap sold as a cosmetic product in some places but a drug in others?

A: The product classification (as a drug or a cosmetic) is determined by various national regulatory bodies based on the claims being made for its use. If a product contains the active component at concentrations intended to treat a condition (like anti-dandruff), it is regulated as a drug; if only cosmetic claims are made, it may be regulated as a cosmetic.


Q: Can I use Skin-cap on my whole body at once?

A: Official warnings on the product label advise users to consult a doctor before using the product if the skin condition covers a large area of the body. This advice generally covers the intent of using the product extensively over the entire body.


Q: Does Skin-cap have an expiration date I need to watch out for?

A: Yes, as a product regulated under pharmaceutical standards (GMP), the manufacturer is required to determine and print a stability date, often labeled as an expiration date, on the container. This date indicates the period during which the product retains its full strength and quality.


Q: Is the fragrance in Skin-cap likely to cause irritation?

A: The product information lists general skin irritation as a potential adverse reaction. The inactive ingredient list often includes 'fragrance,' which is a known potential irritant. If any irritation is experienced, official guidance describes discontinuing the use of the product.


Q: What should I do if I use too much Skin-cap?

A: If the product is swallowed, regulatory warnings mandate seeking medical help or contacting a Poison Control Center right away. For excessive application to the skin, the general safety advice is to consult a healthcare professional if the skin condition worsens or fails to improve after use.


Q: Is the zinc pyrithione concentration in Skin-cap standard?

A: The concentration of the active ingredient, Pyrithione Zinc, is typically used within a specific range. For anti-dandruff and anti-seborrheic dermatitis products sold over-the-counter, regulatory monographs define the approved concentration limits (e.g., typically 1.0% to 2.0%) for use.


Q: What is the function of the specific alcohol component in the spray?

A: In spray and liquid formulations, alcohol (such as SD Alcohol) is included as an inactive ingredient with multiple roles. These roles typically include acting as a solvent to fully suspend the active ingredient, enhancing its penetration into the skin surface, and serving as an antimicrobial agent.


Q: Are there any foods or drinks that should be avoided when using Skin-cap?

A: Due to the topical administration and minimal systemic absorption of the labeled active ingredient, official regulatory sources typically do not document specific interactions with common foods, alcohol, or tobacco products.


Q: Does the product help to prevent skin flare-ups?

A: The product is formally indicated to help control the symptoms of conditions like dandruff and seborrheic dermatitis. Directions advise continued use, such as applying at least twice a week, specifically to maintain this control and help reduce the occurrence of symptoms.


Q: Is Skin-cap suitable for people with sensitive skin?

A: General human safety studies often classify the active ingredient, Pyrithione Zinc, as generally non-irritating and non-sensitizing for its approved use. However, official labeling for the product still lists skin irritation as a potential adverse effect, suggesting individual reactions may vary.

How should Skin-cap be stored and disposed of?

How to Store and Dispose of Skin-cap?

The official storage conditions for Skin-cap, which contains Pyrithione Zinc, require that the product be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be kept in its closed container and protected from environmental factors, specifically by keeping it away from heat, moisture, and direct light, and preventing it from freezing.

Child Safety and Disposal

It is mandatory to store the product out of the reach of children to prevent accidental ingestion. Unused or expired medication must be disposed of in accordance with local regulations for pharmaceutical waste. If a take-back program is unavailable, authorities recommend mixing the medicine with an unappealing substance, sealing it, and discarding it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Skin-cap found in:

A-Z Index: